TP53 and thymus lymphoma: It is possible that the intrinsic G2/M cell-cycle checkpoint defects in Brca1−/−;Trp53bp1−/− cells alleviate the requirement for Trp53 mutations and offer growth advantage to allow rapid development of thymic lymphomas.